Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Japanese encephalitis
Pneumococcal disease
NITAG documentation
2013
2012
Clear all
Type of publications
NITAG documentation
(7)
SAGE documentation
(1)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(16)
Topics
Agenda & Minutes
(1)
Recommendation
(6)
Available to download in languages
English (EN)
(7)
Dutch (NL)
(1)
Regions
Americas
(4)
Europe
(2)
South-East Asia
(1)
Countries
Diseases
Japanese encephalitis
(2)
Pneumococcal disease
(5)
Diphtheria
(3)
Haemophilus influenzae type B
(3)
Hepatitis A
(1)
Hepatitis B
(1)
Human papillomavirus (HPV)
(9)
Influenza
(8)
Measles
(2)
Meningococcal disease
(5)
Pertussis
(1)
Rabies
(1)
Rotavirus
(4)
Varicella
(3)
Vaccine topics
Target population
Publication date
2013
(5)
2012
(2)
2024
(4)
2023
(29)
2022
(80)
2021
(165)
2020
(85)
2019
(9)
2018
(13)
2017
(5)
2016
(5)
2015
(5)
2014
(5)
2011
(5)
2010
(8)
2008
(3)
2006
(1)
2005
(1)
2004
(2)
2003
(3)
2002
(2)
1997
(1)
7 results found
2013
∙
Health Council of the Netherlands
Vaccination of infants against pneumococcal infections (3) – 27 November 2013
2013
∙
JCVI
JCVI statement on the wider use of pneumococcal conjugate vaccines in the UK
2013
∙
NTAGI
Minutes of the meeting of NTAGI in 2013
2013
∙
ACIP
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions
2013
∙
ACIP
Use of Japanese Encephalitis Vaccine in Children
2012
∙
ACIP
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
2012
∙
ACIP
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register